Sort
50,496 grants matching “lung cancer”
Dissecting and Targeting RB1-Mutant Osteosarcoma
$420,814Dung-Fang Lee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · CA
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy
$420,763Gary D Kao · University Of Pennsylvania · R01 · FY2019 · CA
Project 1: Evolution of transcriptional programs in lung cancer progression
$420,760Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2021 · CA
Project 1: Evolution of transcriptional programs in lung cancer progression
$420,760Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2020 · CA
Project 1: Evolution of transcriptional programs in lung cancer progression
$420,760Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2017 · CA
Project 1: Evolution of transcriptional programs in lung cancer progression
$420,760Tyler E Jacks · Massachusetts Institute Of Technology · P01 · FY2018 · CA
A Novel Device to Allow Zoom-In Imaging for PET Scanners
$420,742Washington University · R33 · FY2005 · CA
The Role of Carboxypeptidase E in Cancer
$420,686Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Benefits and Harms of Lung Cancer Screening in HIV Infection
$420,665Kristina Anne Crothers · University Of Washington · R01 · FY2016 · CA
Epidemiologic Studies of Germline Polymorphisms in miRNA Pathways: Risk of Lung Cancer Development and Recurrence
$420,606Xifeng Wu · Ut Southwestern Medical Center · P50 · FY2016 · CA
Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology
$420,583K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2025 · CA
Clinical models for evaluating PREPs for tobacco users
$420,582Thomas Evan Eissenberg · Virginia Commonwealth University · R01 · FY2008 · CA
University of Colorado Southwest Oncology Group
$420,576Anthony D Elias · University Of Colorado Denver · U10 · FY2008 · CA
Improving liver lesion biopsy in the CT suite through fusion with PET images
$420,524Kevin Robert Cleary · Kitware, Inc. · R42 · FY2013 · CA
A Randomized trial of early palliative care for newly diagnosed cancer patients
$420,504Jennifer Temel · Massachusetts General Hospital · R01 · FY2011 · NR
VALIDATING USP27X AS A DRUG TARGET IN LUNG CANCER
$420,500Health Research, Inc. · · FY2021 · Defense Health Agency
Inhibition of Radiation-Induced Coronary Microvascular Disease
$420,500Saraswati Pokharel · Roswell Park Cancer Institute Corp · R01 · FY2021 · HL
Phase IbTrial of Rintatolimod and IFNa Regimen in Cancer Patients with Mild or Moderate COVID-19 infection
$420,500Candace S Johnson · Roswell Park Cancer Institute Corp · P30 · FY2020 · CA
Treg Migration in GVHD
$420,446Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R56 · FY2011 · AI
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
$420,442Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy
$420,407Yevgeniy Vinogradskiy · Thomas Jefferson University · UH3 · FY2025 · CA
Exploratory studies of cellular resistance to MTA-cooperative PRMT5 inhibitors in MTAP-loss tumors.
$420,400Jordi Rodon Ahnert · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
National Lung Screening Trial (NLST)
$420,380Claudine Isaacs · Georgetown University · N01 · FY2009 · CA
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
$420,375Roberto Chiarle · Boston Children'S Hospital · R01 · FY2025 · CA
Dissecting KRAS oncoprotein signaling with small molecule inhibitors
$420,375Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA